1. Celecoxib/rofecoxib: ADRs in Belgium

   News item 09 February 2013 Pages: 2 - 2

2. MCA says Psoralea corylifolia products `should not be used'

   News item 09 February 2013 Pages: 2 - 2

3. Olanzapine-associated striae: 5 cases in adolescents in Sweden

   Case reports 09 February 2013 Pages: 2 - 2

4. Propofol contraindicated in patients aged ≤ 16 years in UK

   News item 09 February 2013 Pages: 3 - 3

5. Serious ADRs in general practice in France

   Clinical study 09 February 2013 Pages: 3 - 3

6. Serious ADRs with use of nevirapine in HIV PEP

   News item 09 February 2013 Pages: 3 - 3

7. GI effects of mycophenolate mofetil are of `major concern'

   Review 09 February 2013 Pages: 4 - 4

8. Ribavirin: birth outcome following maternal or paternal exposure

   News item 09 February 2013 Pages: 4 - 4

9. Rifampicin/pyrazinamide-induced hepatitis - TB guidelines updated

   News item 09 February 2013 Pages: 4 - 4

10. Chloroquine/hydroxychloroquine: risk of vision disorders appears low following in utero exposure

    Incidence study 09 February 2013 Pages: 5 - 5

11. Epinephrine: cardiovascular effects following scalp infiltration

    Clinical study 09 February 2013 Pages: 5 - 5

12. Orlistat: no apparent adverse effects on bone mineral content and density

    Clinical study 09 February 2013 Pages: 5 - 5

13. Risk of miscarriage not increased with folic acid

    Clinical study 09 February 2013 Pages: 5 - 5

14. Aspirin: more gastric damage in the presence of H. pylori

    Clinical study 09 February 2013 Pages: 6 - 6

15. Omeprazole reduces furazolidone bioavailability

    Volunteers 09 February 2013 Pages: 6 - 6

16. Varicella virus vaccine: no apparent risk of congenital abnormalities

    Incidence study 09 February 2013 Pages: 6 - 6

17. Amoxicillin/clavulanic acid

    Case report 09 February 2013 Pages: 7 - 7

18. Antiretrovirals

    Case report 09 February 2013 Pages: 7 - 7

19. Arsenic

    Case report 09 February 2013 Pages: 7 - 7

20. Azathioprine/cyclosporin

    Case report 09 February 2013 Pages: 7 - 8

21. Befunolol

    Case report 09 February 2013 Pages: 8 - 8

22. Bupivacaine

    Case reports 09 February 2013 Pages: 8 - 8

23. Celecoxib

    Case report 09 February 2013 Pages: 8 - 8

24. Celecoxib/rofecoxib

    Case reports 09 February 2013 Pages: 8 - 9

25. Ciprofloxacin/vancomycin

    Case report 09 February 2013 Pages: 9 - 9

26. Clozapine/haloperidol

    Case report 09 February 2013 Pages: 9 - 9

27. Cotrimoxazole

    Case report 09 February 2013 Pages: 9 - 9

28. Efavirenz

    Case reports 09 February 2013 Pages: 9 - 10

29. Enoxaparin sodium/nadroparin calcium

    Case reports 09 February 2013 Pages: 10 - 10

30. Mesalazine

    Case report 09 February 2013 Pages: 10 - 10

31. Methylprednisolone

    Case reports 09 February 2013 Pages: 10 - 11

32. Ofloxacin

    Case report 09 February 2013 Pages: 11 - 11

33. Quetiapine

    Case report 09 February 2013 Pages: 11 - 11

34. Ranitidine

    Case report 09 February 2013 Pages: 11 - 11

35. Risperidone

    Case report 09 February 2013 Pages: 11 - 11

36. Rituximab

    Case report 09 February 2013 Pages: 11 - 12